CNSC-36. VRK1 IS A PARALOG SYNTHETIC LETHAL TARGET IN VRK2-METHYLATED GLIOBLASTOMA
نویسندگان
چکیده
Abstract Synthetic lethality — a genetic interaction that results in cell death when two deficiencies co-occur but not either deficiency occurs alone can be co-opted for cancer therapeutics. A pair of paralog genes is among the most straightforward synthetic lethal by virtue their redundant functions. Here we demonstrate paralog-based targeting Vaccinia-Related Kinase 1 (VRK1) 2 (VRK2)-methylated glioblastoma (GBM). VRK2 silenced promoter methylation approximately two-thirds GBM, an aggressive with few available targeted therapies. Genetic knockdown VRK1 VRK2-methylated GBM lines and patient-derived models was resulted decreased activity downstream substrate Barrier to Autointegration Factor (BAF), regulator post-mitotic nuclear envelope formation. knockdown, thus reduced BAF activity, caused lobulation, blebbing micronucleation, which subsequently G2/M arrest DNA damage. The VRK1-VRK2 dependent on kinase rescued ectopic expression. Knockdown led robust tumor growth inhibition xenografts. These indicate inhibiting could viable therapeutic strategy GBM.
منابع مشابه
Differential Inhibitor Sensitivity between Human Kinases VRK1 and VRK2
Human vaccinia-related kinases (VRK1 and VRK2) are atypical active Ser-Thr kinases implicated in control of cell cycle entry, apoptosis and autophagy, and affect signalling by mitogen activated protein kinases (MAPK). The specific structural differences in VRK catalytic sites make them suitable candidates for development of specific inhibitors. In this work we have determined the sensitivity of...
متن کاملIs cytomegalovirus a therapeutic target in glioblastoma?
Several investigators have now demonstrated the expression of genes unique to cytomegalovirus (CMV) in malignant gliomas. Many of these genes promote oncogenesis, alter tumor microenvironment, and serve as immunologic targets. Is the level of CMV infection within tumor cells sufficient to drive important oncogenic or immunosuppressive processes? Can CMV serve as a target for therapeutic interve...
متن کاملThe C/H3 Domain of p300 Is Required to Protect VRK1 and VRK2 from their Downregulation Induced by p53
BACKGROUND The vaccinia-related kinase 1 (VRK1) protein, an activator of p53, can be proteolytically downregulated by an indirect mechanism, which requires p53-dependent transcription. PRINCIPAL FINDINGS In this work we have biochemically characterized the contribution of several p53 transcriptional cofactors with acetyl transferase activity to the induction of VRK1 downregulation that was us...
متن کاملSynthetic lethal interaction between the tumour suppressor STAG2 and its paralog STAG1
Cohesin is a multi-protein complex that tethers sister chromatids during mitosis and mediates DNA repair, genome compartmentalisation and regulation of gene expression. Cohesin subunits frequently acquire cancer loss-of-function alterations and act as tumour suppressors in several tumour types. This has led to increased interest in cohesin as potential target in anti-cancer therapy. Here we sho...
متن کاملCorrection: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours
[This corrects the article DOI: 10.1371/journal.pone.0149099.].
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neuro-oncology
سال: 2022
ISSN: ['1523-5866', '1522-8517']
DOI: https://doi.org/10.1093/neuonc/noac209.116